Cetera Trust Company, N.A Astrazeneca PLC Call Options Transaction History
Cetera Trust Company, N.A
- $166 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,280Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.79 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.84 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.36 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.7 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...